The learn about is being performed in collaboration with the Biomedical Advanced Research and Development Authority (BARDA).
“Our goal is to generate data in the spring of 2021 that will support the use of mRNA-1273 in adolescents in advance of the 2021 school year,” mentioned Chief Executive Officer Stéphane Bancel.
The information comes because the United States prepares to start out distributing the primary doses of COVID-19 vaccines from each Moderna and rival Pfizer/BioNTech to adults, upon regulatory nod for emergency use.
A panel of out of doors advisers to the U.S. Food and Drug Administration will meet on Thursday to talk about whether or not to suggest the usage of Pfizer’s vaccine for other people elderly 16 and older. A equivalent assembly of advisers to the FDA is scheduled for Dec. 17 to talk about Moderna’s vaccine.
Rival Pfizer may be learning its vaccine candidate in individuals as younger as 12.
Disclaimer: This put up has been auto-published from an company feed with none changes to the textual content and has now not been reviewed by way of an editor